Vanessa Ames Wittman - 18 Sep 2026 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Reporting relationship: Director
Issuer ticker: OSCR
Reported as of: 18 Sep 2026
Net transaction value: -$806,000
SEC form: 4
Accepted by SEC: 22 Sep 2026, 16:20:05 UTC
Prior SEC filing: 18 Aug 2026
Next SEC filing: 01 Oct 2026
Source filing: View source filing
Reporting owner signature: /s/Melissa Curtin, Attorney-in-fact

Filing notes and source

Key filing fact

Vanessa Ames Wittman filed Form 4 for Oscar Health, Inc. (OSCR) on 22 Sep 2026.

Key facts

This page summarizes Vanessa Ames Wittman's Form 4 filing for Oscar Health, Inc. (OSCR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Sep 2026, 16:20.

Change

Previous filing in this sequence was filed on 18 Aug 2026.
Current net transaction value: -$806,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001229265 Primary reporting owner

WITTMAN VANESSA AMES

Relationship: Director
Address: 75 VARICK STREET, 5TH FLOOR, NEW YORK
Signature: /s/Melissa Curtin, Attorney-in-fact
Signature date: 22 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OSCR transaction

Class A Common Stock

Sale

Transaction value: -$806,000
Shares: -25,000
Change %: -18%
Price: $32.24
Shares after: 112,121
Date: 18 Sep 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2026.

Footnote F2

Includes shares to be issued in connection with the vesting of one or more restricted stock units.